Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
212 studies found for:    Emtricitabina/ Fumarato de disoproxilo de tenofovir OR Truvada[TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
21 Completed A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)
Condition: HIV Infections
Interventions: Drug: Doravirine;   Drug: Efavirenz;   Drug: TRUVADA®
22 Suspended On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
Condition: HIV Infection
Interventions: Drug: Truvada;   Drug: Placebo
23 Completed Raltegravir as Early Therapy in African-Americans Living With HIV Study
Condition: HIV Infections
Intervention: Drug: Raltegravir + Truvada
24 Completed
Has Results
A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)
Condition: HIV Infections
Interventions: Drug: MK-0518;   Drug: Comparator: efavirenz;   Drug: Comparator: Truvada;   Drug: Comparator: Placebo to MK-0518;   Drug: Comparator: Placebo to efavirenz
25 Unknown  Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
Condition: HIV Infections
Interventions: Drug: Truvada (tenofovir/emitricitabine);   Drug: Kaletra (lopinavir/ritonavir)
26 Completed
Has Results
Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada
Condition: HIV-1
Interventions: Drug: Truvada;   Drug: Zidovudine/lamivudine
27 Recruiting Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Condition: HIV
Interventions: Drug: Truvada qd;   Drug: Maraviroc 300 qd
28 Completed
Has Results
Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men
Conditions: Amphetamine-Related Disorders;   HIV;   HIV Infections
Interventions: Drug: Truvada;   Behavioral: CM
29 Completed Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)
Condition: HIV Infections
Interventions: Drug: Vicriviroc;   Drug: emtricitabine and tenofovir disoproxil fumarate
30 Completed
Has Results
Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)
Condition: HIV
Interventions: Drug: Truvada;   Drug: Raltegravir
31 Active, not recruiting
Has Results
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Condition: HIV Infection
Interventions: Drug: Reformulated Raltegravir;   Drug: Raltegravir;   Drug: TRUVADA™;   Drug: Placebo to Reformulated Raltegravir;   Drug: Placebo to Raltegravir
32 Completed SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: zidovudine and lamivudine (Combivir®);   Drug: emtricitabine and tenofovir DF
33 Recruiting Introducing PrEP Into HIV Combination Prevention - Kenya
Condition: HIV
Intervention: Drug: Truvada
34 Completed Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients
Conditions: Hepatitis B;   HIV Infections
Interventions: Drug: TRUVADA (EMTRICITABINE + TENOFOVIR DF);   Biological: PEGASYS 180μg (Interféron pégylé alpha -2a)
35 Terminated
Has Results
Artery Elasticity After Switch From Epzicom to Truvada
Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil
36 Completed
Has Results
Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects
Condition: HIV
Interventions: Drug: Truvada;   Drug: Combivir;   Drug: Trizivir
37 Completed PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5
Conditions: HIV;   Human Immunodeficiency Virus
Intervention: Drug: Tenofovir/emtricitabine
38 Completed A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP
Condition: HIV Infections
Intervention: Drug: AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
39 Not yet recruiting Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities
Condition: HIV Infections
Interventions: Drug: Truvada;   Drug: Genvoya
40 Completed
Has Results
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: ATV;   Drug: Ritonavir;   Drug: FTC/TDF;   Drug: Stribild Placebo;   Drug: ATV Placebo;   Drug: RTV Placebo;   Drug: FTC/TDF Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.